These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 230994)

  • 21. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg.
    Nath N; Fang CT; Fields HA; Doto IL; Maynard JE
    J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.
    Arnold W; Hess G; Kawakami H; Meyer zum Büschenfelde KH
    Klin Wochenschr; 1981 Jun; 59(12):679-83. PubMed ID: 7253542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
    Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
    Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
    Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
    J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of hepatitis B e-antigen in chronic hepatitis B infection.
    Norkrans G; Lindberg J; Frösner G; Hermodsson S; Lundin P; Iwarson S
    Scand J Gastroenterol; 1982 Apr; 17(3):383-7. PubMed ID: 7134865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta agent and the etiology of hepatocellular carcinoma.
    Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
    Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
    Antoniozzi F; Meucci G; Vecchi M; Ronchi G; Collatina R; Del Ninno E; de Franchis R
    Boll Ist Sieroter Milan; 1986; 65(5):347-53. PubMed ID: 3828089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus infection and primary hepatocellular carcinoma.
    Tabor E; Gerety RJ; Vogel CL; Bayley AC; Anthony PP; Chan CH; Barker LF
    J Natl Cancer Inst; 1977 May; 58(5):1197-200. PubMed ID: 192895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers.
    Lohiya G; Lohiya S; Ngo VT; Crinella R
    Hepatology; 1986; 6(2):163-6. PubMed ID: 2937706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays.
    Mushahwar IK; Overby LR; Frosner G; Deinhardt F; Ling CM
    J Med Virol; 1978; 2(2):77-87. PubMed ID: 670950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis.
    Aldershvile J; Frösner GG; Nielsen JO; Hardt F; Deinhardt F; Skinhøj P
    J Infect Dis; 1980 Mar; 141(3):293-8. PubMed ID: 7365280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of the HBe system in an area highly endemic for hepatitis B virus.
    Del Vecchio-Blanco C; Caporaso N; Balzano A; Ambrogio G; Aldershvile J; Juhl E; Nielsen JO
    Infection; 1983; 11(1):13-6. PubMed ID: 6840863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of e antigen as prognostic marker in acute hepatitis B.
    Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
    Infection; 1979; 7(1):17-20. PubMed ID: 84794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells.
    Suzuki K; Uchida T; Horiuchi R; Shikata T
    Cancer; 1985 Jul; 56(2):321-7. PubMed ID: 2988742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.